Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.

Roy O. Mathew; Elvira O. Gosmanova; Mandeep S. Sidhu

doi:10.1007/s10557-018-6803-0

Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.

Roy O. Mathew
, Elvira O. Gosmanova
, Mandeep S. Sidhu

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	241-243
Number of pages	3
Journal	Cardiovascular Drugs and Therapy
Volume	32
Issue number	3
DOIs	https://doi.org/10.1007/s10557-018-6803-0
State	Published - Jun 1 2018
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Keywords

Aspirin
Cardiovascular Diseases
Primary Prevention
Renal Insufficiency, Chronic
Humans
Disease Progression

Access to Document

10.1007/s10557-018-6803-0

OpenUrl availability

Full text

Cite this

Mathew, R. O., Gosmanova, E. O., & Sidhu, M. S. (2018). Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. Cardiovascular Drugs and Therapy, 32(3), 241-243. https://doi.org/10.1007/s10557-018-6803-0

Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. / Mathew, Roy O.; Gosmanova, Elvira O.; Sidhu, Mandeep S.
In: Cardiovascular Drugs and Therapy, Vol. 32, No. 3, 01.06.2018, p. 241-243.

Research output: Contribution to journal › Editorial › peer-review

Mathew, RO, Gosmanova, EO & Sidhu, MS 2018, 'Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.', Cardiovascular Drugs and Therapy, vol. 32, no. 3, pp. 241-243. https://doi.org/10.1007/s10557-018-6803-0

Mathew RO, Gosmanova EO, Sidhu MS. Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. Cardiovascular Drugs and Therapy. 2018 Jun 1;32(3):241-243. doi: 10.1007/s10557-018-6803-0

Mathew, Roy O. ; Gosmanova, Elvira O. ; Sidhu, Mandeep S. / Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease : Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. In: Cardiovascular Drugs and Therapy. 2018 ; Vol. 32, No. 3. pp. 241-243.

@article{2fd01b08075a44ce99574affd65d060b,

title = "Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.",

keywords = "Aspirin, Cardiovascular Diseases, Primary Prevention, Renal Insufficiency, Chronic, Humans, Disease Progression",

author = "Mathew, \{Roy O.\} and Gosmanova, \{Elvira O.\} and Sidhu, \{Mandeep S.\}",

year = "2018",

month = jun,

day = "1",

doi = "10.1007/s10557-018-6803-0",

language = "English",

volume = "32",

pages = "241--243",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

number = "3",

}

TY - JOUR

T1 - Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease

T2 - Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.

AU - Mathew, Roy O.

AU - Gosmanova, Elvira O.

AU - Sidhu, Mandeep S.

PY - 2018/6/1

Y1 - 2018/6/1

KW - Aspirin

KW - Cardiovascular Diseases

KW - Primary Prevention

KW - Renal Insufficiency, Chronic

KW - Humans

KW - Disease Progression

UR - https://www.scopus.com/pages/publications/85048765459

UR - https://www.scopus.com/pages/publications/85048765459#tab=citedBy

UR - https://www.mendeley.com/catalogue/e733c79d-b12d-35c3-b96c-a12d5d5c2c5f/

U2 - 10.1007/s10557-018-6803-0

DO - 10.1007/s10557-018-6803-0

M3 - Editorial

C2 - 29923131

AN - SCOPUS:85048765459

SN - 0920-3206

VL - 32

SP - 241

EP - 243

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 3

ER -

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this